Push launch MHRA approves GLP –1 receptor agonist semaglutide to cut back danger of significant heart complications in obese or overweight Grown ups Semaglutide is the very first weightloss drug accredited in the UK like a preventative treatment for anyone with founded cardiovascular diseaseIndividuals taking Wegovy or Mounjaro commonly start to